Risk of de novo psoriasis in hypertension patients initially treated with beta-blockers: Nationwide population-based cohort study in Korea

J Eur Acad Dermatol Venereol. 2022 Mar;36(3):e202-e205. doi: 10.1111/jdv.17733. Epub 2021 Oct 28.

Authors

Y E Kim¹, Y Cho², S J Jo¹

Affiliations

¹ Department of Dermatology, Seoul National University College of Medicine, Seoul, South Korea.
² Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

PMID: 34626505
DOI: 10.1111/jdv.17733

No abstract available

Publication types

Letter

MeSH terms

Adrenergic beta-Antagonists / adverse effects
Cohort Studies
Humans
Hypertension* / drug therapy
Hypertension* / epidemiology
Psoriasis* / drug therapy
Psoriasis* / epidemiology
Republic of Korea / epidemiology
Risk Factors

Substances

Adrenergic beta-Antagonists